RadNet (RDNT) Competitors

$59.04 +0.79 (+1.35%)

Closing price 03:59 PM Eastern

Extended Trading

$59.04 -0.01 (-0.01%)

As of 05:05 PM Eastern

RDNT vs. FMS, GH, BTSG, HIMS, and CELC

Should you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fresenius Medical Care AG & Co. KGaA (FMS), Guardant Health (GH), BrightSpring Health Services (BTSG), Hims & Hers Health (HIMS), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

: Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA $19.63B 0.57 $1.11B $1.91 10.55
RadNet $2.04B 2.27 -$18.65M -$0.25 N/A
: Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, RadNet has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500.
: In the previous week, Fresenius Medical Care AG & Co. KGaA had 3 more articles in the media than RadNet. MarketBeat recorded 13 mentions for Fresenius Medical Care AG & Co. KGaA and 10 mentions for RadNet. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.60 beat RadNet's score of 0.28 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
3 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
: 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 5.6% of RadNet shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
: Fresenius Medical Care AG & Co. KGaA has a net margin of 5.03% compared to RadNet's net margin of -0.91%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.73% beat RadNet's return on equity.
Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA 5.03% 8.73% 4.02%
RadNet -0.91% 2.52% 0.88%
: Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $28.00, indicating a potential upside of 38.92%. RadNet has a consensus price target of $88.14, indicating a potential upside of 49.28%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than Fresenius Medical Care AG & Co. KGaA.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
4 Sell rating(s)
6 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.60
RadNet
1 Sell rating(s)

1 Hold rating(s)

6 Buy rating(s)

2 Strong Buy rating(s)
2.90

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$19.63B	0.57	$1.11B	$1.91	10.55
RadNet	$2.04B	2.27	-$18.65M	-$0.25	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	5.03%	8.73%	4.02%
RadNet	-0.91%	2.52%	0.88%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

Summary

Fresenius Medical Care AG & Co. KGaA beats RadNet on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to Guardant Health?

RadNet (NASDAQ:RDNT) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

: 77.9% of RadNet shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 5.6% of RadNet shares are held by insiders. Comparatively, 6.1% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
: RadNet currently has a consensus target price of $88.14, indicating a potential upside of 49.28%. Guardant Health has a consensus target price of $128.63, indicating a potential upside of 43.63%. Given RadNet's stronger consensus rating and higher possible upside, equities analysts plainly believe RadNet is more favorable than Guardant Health.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
1 Sell rating(s)
1 Hold rating(s)

6 Buy rating(s)

2 Strong Buy rating(s)
2.90
Guardant Health
1 Sell rating(s)

1 Hold rating(s)

19 Buy rating(s)

0 Strong Buy rating(s)
2.86
: In the previous week, Guardant Health had 9 more articles in the media than RadNet. MarketBeat recorded 19 mentions for Guardant Health and 10 mentions for RadNet. Guardant Health's average media sentiment score of 0.62 beat RadNet's score of 0.28 indicating that Guardant Health is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
3 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Guardant Health
9 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
: RadNet has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500.
: RadNet has a net margin of -0.91% compared to Guardant Health's net margin of -42.39%. RadNet's return on equity of 2.52% beat Guardant Health's return on equity.
Company Net Margins Return on Equity Return on Assets
RadNet -0.91% 2.52% 0.88%
Guardant Health -42.39% N/A -27.82%
: RadNet has higher revenue and earnings than Guardant Health. RadNet is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
RadNet $2.04B 2.27 -$18.65M -$0.25 N/A
Guardant Health $982.02M 12.09 -$416.28M -$3.31 N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	9 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.91%	2.52%	0.88%
Guardant Health	-42.39%	N/A	-27.82%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.27	-$18.65M	-$0.25	N/A
Guardant Health	$982.02M	12.09	-$416.28M	-$3.31	N/A

Summary

RadNet beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and RadNet (NASDAQ:RDNT) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations.

: In the previous week, BrightSpring Health Services had 15 more articles in the media than RadNet. MarketBeat recorded 25 mentions for BrightSpring Health Services and 10 mentions for RadNet. BrightSpring Health Services' average media sentiment score of 0.74 beat RadNet's score of 0.28 indicating that BrightSpring Health Services is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
9 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
3 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
: BrightSpring Health Services currently has a consensus target price of $55.29, suggesting a potential upside of 7.48%. RadNet has a consensus target price of $88.14, suggesting a potential upside of 49.28%. Given RadNet's higher probable upside, analysts clearly believe RadNet is more favorable than BrightSpring Health Services.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)

14 Buy rating(s)

2 Strong Buy rating(s)
3.06
RadNet
1 Sell rating(s)

1 Hold rating(s)

6 Buy rating(s)

2 Strong Buy rating(s)
2.90
: BrightSpring Health Services has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BrightSpring Health Services $12.91B 0.77 $190.67M $1.41 36.48
RadNet $2.04B 2.27 -$18.65M -$0.25 N/A
: 77.9% of RadNet shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 5.6% of RadNet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
: BrightSpring Health Services has a beta of 1.71, suggesting that its stock price is 71% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.43, suggesting that its stock price is 43% more volatile than the S&P 500.
: BrightSpring Health Services has a net margin of 2.27% compared to RadNet's net margin of -0.91%. BrightSpring Health Services' return on equity of 14.63% beat RadNet's return on equity.
Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services 2.27% 14.63% 4.41%
RadNet -0.91% 2.52% 0.88%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	9 Very Positive mention(s)	3 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	1 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	3.06
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	0.77	$190.67M	$1.41	36.48
RadNet	$2.04B	2.27	-$18.65M	-$0.25	N/A

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
RadNet	-0.91%	2.52%	0.88%

Summary

BrightSpring Health Services beats RadNet on 12 of the 16 factors compared between the two stocks.

How does RadNet compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and RadNet (NASDAQ:RDNT) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

: Hims & Hers Health has a beta of 2.43, meaning that its stock price is 143% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.43, meaning that its stock price is 43% more volatile than the S&P 500.
: 63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 5.6% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: Hims & Hers Health has a net margin of 5.47% compared to RadNet's net margin of -0.91%. Hims & Hers Health's return on equity of 22.48% beat RadNet's return on equity.
Company Net Margins Return on Equity Return on Assets
Hims & Hers Health 5.47% 22.48% 7.02%
RadNet -0.91% 2.52% 0.88%
: Hims & Hers Health has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Hims & Hers Health $2.35B 2.56 $128.37M $0.51 51.67
RadNet $2.04B 2.27 -$18.65M -$0.25 N/A
: Hims & Hers Health presently has a consensus target price of $32.33, suggesting a potential upside of 22.69%. RadNet has a consensus target price of $88.14, suggesting a potential upside of 49.28%. Given RadNet's stronger consensus rating and higher possible upside, analysts plainly believe RadNet is more favorable than Hims & Hers Health.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
13 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.17
RadNet
1 Sell rating(s)

1 Hold rating(s)

6 Buy rating(s)

2 Strong Buy rating(s)
2.90
: In the previous week, Hims & Hers Health had 8 more articles in the media than RadNet. MarketBeat recorded 18 mentions for Hims & Hers Health and 10 mentions for RadNet. Hims & Hers Health's average media sentiment score of 0.59 beat RadNet's score of 0.28 indicating that Hims & Hers Health is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
5 Very Positive mention(s)
6 Positive mention(s)
4 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
3 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	5.47%	22.48%	7.02%
RadNet	-0.91%	2.52%	0.88%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.56	$128.37M	$0.51	51.67
RadNet	$2.04B	2.27	-$18.65M	-$0.25	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	13 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.17
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	5 Very Positive mention(s)	6 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Hims & Hers Health beats RadNet on 12 of the 17 factors compared between the two stocks.

How does RadNet compare to Celcuity?

RadNet (NASDAQ:RDNT) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends.

: RadNet has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500.
: In the previous week, Celcuity had 7 more articles in the media than RadNet. MarketBeat recorded 17 mentions for Celcuity and 10 mentions for RadNet. Celcuity's average media sentiment score of 0.33 beat RadNet's score of 0.28 indicating that Celcuity is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
3 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Celcuity
7 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Celcuity has a net margin of 0.00% compared to RadNet's net margin of -0.91%. RadNet's return on equity of 2.52% beat Celcuity's return on equity.
Company Net Margins Return on Equity Return on Assets
RadNet -0.91% 2.52% 0.88%
Celcuity N/A -203.17% -52.68%
: 77.9% of RadNet shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Comparatively, 13.3% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: RadNet currently has a consensus price target of $88.14, indicating a potential upside of 49.28%. Celcuity has a consensus price target of $134.50, indicating a potential downside of 5.12%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts plainly believe RadNet is more favorable than Celcuity.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
1 Sell rating(s)
1 Hold rating(s)

6 Buy rating(s)

2 Strong Buy rating(s)
2.90
Celcuity
1 Sell rating(s)

1 Hold rating(s)

10 Buy rating(s)

0 Strong Buy rating(s)
2.75
: RadNet has higher revenue and earnings than Celcuity. RadNet is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
RadNet $2.04B 2.27 -$18.65M -$0.25 N/A
Celcuity N/A N/A -$177.04M -$3.79 N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	3 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Celcuity	7 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.91%	2.52%	0.88%
Celcuity	N/A	-203.17%	-52.68%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Celcuity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.27	-$18.65M	-$0.25	N/A
Celcuity	N/A	N/A	-$177.04M	-$3.79	N/A

Summary

RadNet beats Celcuity on 10 of the 16 factors compared between the two stocks.

Get RadNet News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RDNT vs. The Competition

Export

Metric	RadNet	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$4.62B	$5.53B	$6.25B	$11.87B
Dividend Yield	N/A	1.44%	2.73%	5.21%
P/E Ratio	-236.18	42.90	29.04	28.47
Price / Sales	2.27	22.49	476.61	60.92
Price / Cash	17.63	16.21	27.62	36.52
Price / Book	3.36	3.08	9.67	6.67
Net Income	-$18.65M	$218.81M	$3.55B	$332.53M
7 Day Performance	2.00%	-1.87%	1.70%	2.01%
1 Month Performance	7.77%	5.05%	5.62%	9.19%
1 Year Performance	11.13%	21.23%	34.41%	39.59%

RadNet Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RDNT RadNet	2.7934 of 5 stars	$59.05 +1.3%	$88.14 +49.3%	N/A	$4.62B	$2.04B	N/A	11,264	News Coverage Upcoming Earnings
FMS Fresenius Medical Care AG & Co. KGaA	4.5859 of 5 stars	$22.59 -0.8%	$28.00 +23.9%	N/A	$12.72B	$22.20B	11.83	1,488	News Coverage Dividend Increase Gap Down
GH Guardant Health	3.8634 of 5 stars	$88.50 -0.5%	$125.20 +41.5%	N/A	$11.66B	$982.02M	N/A	2,506	News Coverage Upcoming Earnings
BTSG BrightSpring Health Services	3.756 of 5 stars	$48.57 +0.9%	$45.50 -6.3%	N/A	$9.30B	$12.91B	55.19	23,500	Earnings Report Analyst Forecast
HIMS Hims & Hers Health	4.0261 of 5 stars	$29.31 -4.1%	$32.53 +11.0%	N/A	$6.97B	$2.35B	57.48	2,442	Upcoming Earnings Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RDNT) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RadNet (RDNT) Competitors

RDNT vs. FMS, GH, BTSG, HIMS, and CELC

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does RadNet compare to Guardant Health?

Summary

How does RadNet compare to BrightSpring Health Services?

Summary

How does RadNet compare to Hims & Hers Health?

Summary

How does RadNet compare to Celcuity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RadNet (RDNT) Competitors

RDNT vs. FMS, GH, BTSG, HIMS, and CELC

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does RadNet compare to Guardant Health?

Summary

How does RadNet compare to BrightSpring Health Services?

Summary

How does RadNet compare to Hims & Hers Health?

Summary

How does RadNet compare to Celcuity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools